New Research Paper Addressing Concerns about Generic ADHD Medication / Health Canada Up-dates on the Issue

Since 2010 CADDAC has shared our concerns about the direct substitution of methylphenidate ER-C, a generic medication, for OROS® methylphenidate (Concerta) with Health Canada. This was done through documentation, caregiver and patient survey results and several face to face meetings. A Canadian research paper reviewing data on this issue, was recently published in the Clinical…

Australian School Systems Fail Students with ADHD

It was with great interest that I reviewed an Australian study looking at academic achievement in students with ADHD during the period from childhood to adolescence. Having spent the last twenty years speaking with researchers, parents, educators, school boards and Ministries of Education across Canada I firmly believe that this study highlights the same situation…

Antidepressant Use During Early Pregnancy Does Not Increase Risk of Autism or ADHD

A recent study has found that use of antidepressants by the mother during early pregnancy did not significantly increase the risk of poor fetal growth or the child’s risk of developing Autism or ADHD as previously thought. As well, only a slight increased risk for premature birth was found. This is the largest study to…